Abstract
INTRODUCTION
B-cell-type Hodgkin and Reed-Sternberg (HRS) cells of classical Hodgkin lymphoma (cHL) are unable to produce both immunoglobulin (Ig) light (L) chain, 1, 2, 3 and heavy (H) chain 4 despite the presence of clonally rearranged IgL and IgH genes. 5, 4 Two explanations have been considered so far for this Ig down-regulation were: (i), "crippling" mutations within the transcription control regions and/or in the coding sequence, 6 (ii) the absence, or diminished production of critical transcription factors. 7, 8, 9 Crippling mutations in the Ig coding regions can hardly be considered to be a main cause of Ig down-regulation in HRS cells, because the vast majority of cHL cases (75%) harbor functionally rearranged Ig genes without mutations. 4 Likewise, mutations in the Ig-regulatory elements are also not responsible for the absence of Ig transcription because they were found in only one cHLderived cell line L1236 (mutation in the first position of the octamer motif of V H the promoter)
but not in isolated primary HRS cells of all but one cHL case 10,11 , 7 In contrast, the absence or substantial down-regulation of B-cell-specific transcription factors, such as Oct2 and BOB.1/OBF.1 7, 8, 9 as well as the Ets family member PU.1 12, 13, 14 was observed in all cHL cell lines as well as in primary HRS cells of all cHL cases. Forced expression of these factors in cHL-derived cell lines resulted in the activation of co-transfected Ig promoter constructs underscoring their decisive role in the regulation of Ig transcription. 14 Their important role for B-lymphopoiesis and Ig-gene transcription was also shown in knock-out experiments where PU.1 is crucial for the development of several hematopoetic lineages 15 and BOB.1/OBF.1 is critical for high titers of secondary Ig isotypes. 16 , 17 Taking into account that in cHL-derived cell lines class switch recombination is often targeted to IgG4 or IgA, 18 down-regulation of BOB.1/OBF.1 could be the explanation for decreased Ig transcription in many of cHL cases.
Therefore it is an unexprected finding that simultaneous co-transfection of Oct2 and BOB.1/OBF.1 expression plasmids in cHL-derived cell lines is unable reactivate endogenous Ig production. 14 This fact implies the existence of alternative mechanisms of Ig suppression in HRS cells, which are different from genetic mutations and down-regulation of transcription factors.
It has become clear that loss of gene function in cancer cells is mediated -at least as often -by epigenetic factors as by gene mutations. 19 Epigenetic silencing in cancer cells generally proceeds through aberrant promoter CpG methylation, followed by the binding of methyl-binding proteins, and the recruitment of transcriptional co-repressors, chromatin remodeling proteins and histone deacetylases. 20, 21 Finally, modification of histones, induced by such complexes, results in the formation of a condensed chromatin structure, known as a "heterochromatin", which is associated with transcriptionally inactive regions 22 . Epigenetic silencing, in particular, was found to be responsible for down-regulation of numerous tumor suppressor genes such as BRCA1,
23
p16/CDKN2, 24 VHL, 25 p15/INK4B1. 26 In B-cell derived tumors, gene silencing by epigenetic mechanism was shown for p73 27 and B29 genes. 28 In the present study we show that epigenetic silencing also contributes to the down-regulation of Ig expression in cultured and primary HRS cells.
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Material and Methods

Cell lines
The human Burkitt lymphoma cell lines Namalwa and B-JAB, as well as the cHL cell lines L1236, KM-H2 and L428 were cultured in RPMI 1640 medium (Life Technologies, Karlsruhe, Germany) supplemented with 10% fetal bovine serum (PAN, Biotech GmbH, Aidenbach, Germany), antibiotics, L-glutamine and 50 µM of 2-mercaptoethanol at 37 °C and 5% CO 2 . The L428-Oct2 cell line was obtained by stable co-transfection of the L428 cells with a mammalian expression vector containing the full length human Oct2A 29 together with the pcDNA-neo vector.
Positive colonies were selected with 1.3 mg/mL of G-418 (Calbiochem, Bad Soden, Germany).
Control cell line L428-neo was transfected only with the pcDNA-neo vector and selected as Life cell purification by ficoll gradient centrifugation was performed when necessary.
Nucleofection efficiencies were tested in cHL cell lines using co-transfection of BOB.1/OBF.1 and/or Oct2 expressing vectors with pcDNA-EGFP vector (better than 80% for L428, lower efficiencies for KM-H2 and L1236). The cells were harvested and used for ChIP assay the day after nucleofection. 
Chromatin immunoprecipitation (ChIP).
We used the chromatin immunoprecipitation (ChIP) Assay kit #17-295 (Biomol GmbH, Hamburg, Germany) according to the manufacturer´s instructions with some minor modifications. Briefly, 3x10 7 cells were collected in culture medium and then 37% formaldehyde stabilized with 10% of methanol was added to a final concentration of 1% formaldehyde. After 12 minutes of incubation at 37°C, cells were washed twice with cold PBS and re-suspended in 900 µL of lysis buffer containing 1 mM PMSF, 10 µg /ml aprotinin, 10 µg/mL leupeptin and 1 For immunostaining, the acetone-fixed cytospin preparations of cHL cells were incubated with the same polyclonal rabbit antibody against human IgG as described above for Western blots.
Slides were washed in PBS and incubated with an anti rabbit horseradish-peroxidase polymer (EnVision System, Dako A/S). Peroxidase activity was visualized with the substrate 3-amino-9-ethylcarbazole (0.1 mg/ml in 0.17 M sodium acetate, pH 5.2 plus 0.01% H 2 O 2 ). Nuclear counterstaining was done with hematoxylin. For personal use only. on November 12, 2017. by guest www.bloodjournal.org From
Primers and amplification conditions for ChIP and RT-PCR
RESULTS
Transcription factors interact with Ig-octamer motifs in Burkitt lymphoma control cell lines
To find out whether regulatory regions for IgH transcription are accessible for the octamer binding transcription factors Oct1 and Oct2, as well as for the BOB.1/OBF.1 co-activator, we used chromatin immunoprecipitation (ChIP) assays to investigate protein-DNA interactions in living cells. 32 The choice of transcription factors was based on their important role in the regulation of Ig transcription, and because octamer motif(s) are present in all three regulatory regions: the V H promoter, the internal enhancer and the 3´-enhancers.
Because of the high homology among the many IgV H promoters, the primers for amplification of immunoprecipitated DNA were located within 150 bp upstream of the octamer motif and within the CDR3 region ( Figure 1A ).
In all cases, these primer combinations selectively amplified only the rearranged allele in the respective cell line. The internal enhancer region containing a cluster of two imperfect octamer motifs was amplified by flanking primers. The 3´-enhancer hs1,2 located in the C 1 and C 2 locus control regions (LCR) was reported to be more important for the regulation of IgG transcription than other 3´-IgH enhancers (hs3A and hs4). 33, 34 Therefore we amplified the octamer-containing fragment of hs1,2 from the C 1 and C 2 LCRs using the respective specific set of primers (Table 1) . Due to the allelic polymorphism of hs1,2 35, 34 we used different primers for the amplification of the C 2 hs1,2 from KM-H2 cells ( Table 1) . As a control, we amplified the octamer-containing promoter region of the ubiquitously expressed histone H2B gene.
There are, as yet, no data available on the binding of octamer-specific transcription factors to regulatory regions of human IgH in vivo. We therefore determined the binding patterns of Oct1, Oct2 and BOB.1/OBF.1 in the Burkitt lymphoma cell lines Namalwa and B-JAB ( Figure 1B ), which are known to produce Ig and express Oct1, Oct2 and BOB.1/OBF.1 11, 4 .
The results obtained in both cell lines were virtually identical. All three proteins were bound to the octamer motif of the IgV H promoters roughly equally. The binding pattern to the internal enhancer region containing two imperfect octamer motifs was slightly different. Whereas, Oct2 and BOB.1/OBF.1 were present at the internal enhancer, the Oct1 binding signal was nearly undetectable. All three transcription factors were again bound to the C 1 and C 2 enhancers in both cell lines.
However, the amplification signals were stronger in case of the C 1 enhancer. In addition, Oct1, Oct2, and BOB.1/OBF.1, were bound to the H2B control promoter in both Burkitt lymphoma cell lines. The fact that Oct2 signals are stronger than Oct1 signals in B-JAB cells compared to Namalwa cells is most likely due to the fact that B-JAB cells express large amounts of Oct2.
Ig-regulatory elements are not occupied by transcription factors in cHL cell lines
We then investigated whether these regulatory elements are also bound by transcription factors in the cHL-derived cell lines KM-H2, L428 and L1236. We first re-analyzed the status of Oct1, 
L1236
For personal use only. on November 12, 2017. by guest www.bloodjournal.org From LCR by deletional recombination, the germ line C 1 LCR-hs1,2 enhancer product was not amplified in cultured HRS cells (data not shown). To test the binding of these proteins to a control promoter region of a gene expressed in these cells, we again analyzed the H2B promoter.
In L428 and L1236 cells, only Oct1 binding could be scored. In contrast in the KM-H2 cell line, which expresses low amounts of Oct2 protein, we found both Oct1 and Oct2 associated with the H2B promoter. This result confirms that the endogenous proteins are capable of binding to promoter regions. However, the octamer motif(s) of IgH gene regulatory regions are not occupied by these proteins in cHL cell lines.
Ectopically expressed Oct2 and BOB.1/OBF.1 do not bind Ig-regulatory regions in cHL cells
Earlier work has shown that Oct1 is as active as Oct2 in the activation of Ig V H promoters, yet it was shown to be unable to activate the internal enhancer 29 and the 3´-enhancer 36 . Indeed we found almost no interaction between Oct1 and the internal enhancer, even in our control cell lines ( Figure 1B ). However, we had shown earlier that immunoglobulin gene promoter activity can be mediated by Oct1 plus BOB.1/OBF.1, even in the absence of Oct2. We therefore asked, whether our failure to detect binding to the enhancer regions was a consequence of lacking Oct2 and the failure to detect binding to the promoter might be due to a lack of BOB.1/OBF.1.
We therefore ectopically expressed these proteins in cHL cell lines and asked, whether this would affect transcription factor occupancy at the respective Ig regulatory region octamer motifs. L428 cells were first stably transfected with an Oct2 expression vector and then supertransfected with the BOB.1/OBF.1 expression vector using the nucleofection (Amaxa) strategy. This resulted in the generation of L428 derivatives expressing Oct2, BOB.1/OBF.1, or both proteins at levels comparable to the Namalwa control cell line ( Figure 3A) .
We then asked, whether these ectopically expressed proteins were capable of interaction with the endogenous Ig regulatory elements. Interestingly, neither in the cells transfected individually with Oct2 or BOB.1/OBF.1, nor in double positive cells could we detect any significant interaction of these proteins with the Ig regulatory elements. However, the transfected Oct2 was readily able to interact with the octamer motif in the control histone H2B control promoter ( Figure 3B ). In addition to these experiments measuring protein-DNA binding in vivo we also analysed, whether the expression of the endogenous Ig gene was increased in these transfectants. However, we were unable to detect any significant levels of Ig mRNA by RT-PCR (see below figure 6B ). 
to these control regions, but rather that these DNA elements are inaccessible to endogenous and ectopic transcription factors in cHL cell lines.
Inhibition of DNA methylation partially reactivates IgH transcription.
To assess IgH transcription in KM-H2, L1236 and L428 cells we used RT-PCR. cDNA was amplified with sets of primers, specific for each cell line ( Figure 4A ).
The RT-PCR included the leader region to discern contaminating DNA from spliced mRNA amplification signals. All sets of primers showed similar amplification efficiencies (not shown).
In untreated cells, we only found IgH expression (albeit at a very low level) in KM-H2 cells 
The IgH gene promoters show features of inactive chromatin that can be reactivated by inhibition of DNA methylation
Unlike genetic mutations, epigenetic silencing is potentially reversible.
19 DNA methylation is one of the most common mechanisms, which -directly or through formation of a repressive chromatin structure -is involved in the suppression of gene function. 19 The observed partial reactivation of Ig-gene transcription by 5-aza-dC in L428 and L1236 cells suggested that indeed the gene silencing in cHL cell lines might be a consequence of such chromatin modifications. To monitor the chromatin structure we used ChIP with antibodies against methylated lysine 9 in histone H3 (H3-K9Me). Previous work had demonstrated that the local density of H3-K9Me is a reliable marker of "closed" inactive chromatin structure. 37, 38 Methylation of H3-K9 correlates better with heterochromatin formation than histone H3 lysine 4 methylation 37 or the general histone acetylation 39 . As a positive control we amplified immunoprecipitated DNA with primers, specific for the promoter region of involucrin. Involucrin is a tissue-specific gene involved in terminal differentiation of keratinocytes and it is not expressed in lymphoid cells. When we To test this hypothesis we assessed Ig production in L428-neo and L428-Oct2 cell lines treated with 5-aza-dC and nucleofected with BOB.1/OBF.1 expression vector. We measured Ig expression by RT-PCR, Western blot, ELISA, and immunocytochemistry. BOB.1/OBF.1 levels in transfected cells were comparable to the positive control cell lines (Namalwa, UM-1) whereas Oct2 in L428-Oct2 cells was higher than in Namalwa cells. Under these experimental conditions we were able to detect weak Ig RNA expression in L428-Oct2 cells over-expressing BOB.1/OBF.1 by RT-PCR even without 5-aza-dC treatment ( Figure 6B) . Importantly, in all cases RNA-transcription levels were increased by 5-aza-dC and highest levels were observed in cells expressing in addition both Oct2 and BOB.1/OBF.1. We then checked, whether these levels of RNA were sufficient to yield detectable Ig protein levels. We assessed Ig protein production 
Transcription factor occupancy of IgH regulatory regions
Binding of Oct1 and Oct2 to the three transcription regulatory regions of IgH locus (promoter, internal enhancer, 3´enhancers) had been shown in the past by EMSA with extracts from many B-cell lines. In addition, functional data had left little doubt on their physical interaction with the octamer motifs of the Ig promoters. 40 However, it was not clear whether Oct1 and Oct2 would interchangeably bind to the same regions, or whether there would be transcription factor selectivity in vivo. The observed binding of all three transcription factors to the promoter and the 3´-enhancer in Burkitt lymphoma cells suggests that for these regulatory regions, there is no such selectivity. This result is in perfect agreement with published data on the ability of the ubiquitous Oct1 to substitute for the B-cell-specific Oct2 in activating Ig promoters. 41 In contrast, the situation at the internal enhancer does suggest some level of selectivity, which is however, not absolute. The role of octamer-binding factors in regulating the human internal enhancer was unclear in the past. Whereas the mouse counterpart contains a perfect octamer motif, 42,43 the human enhancer has three octamer-like sequences, with lower affinity to Oct transcription factors. 44 The two sites analyzed in the present study show the best conservation to the functional sites. 45 Our ChIP assays reveal that Oct2 and BOB.1/OBF.1, but only very little Oct1 were bound to the internal enhancer of Ig-producing B-cell lines Namalwa and B-JAB. This implies that Oct2 predominantly regulates the function of this motif in the human Ig internal enhancer. This observation is consistent with earlier data where reporter constructs containing the mouse internal enhancer sequence were activated by Oct2, but not by Oct1.
29
3´-IgH enhancer elements lie downstream the C 1 and C 2 regions ( Figure 1A ). Because transgenic constructs containing the 3´-IgH enhancer elements were found to express the reporter gene in position independent manner, they were referred to as locus control regions (LCR). 46 In humans, both C 1 and C 2 LCR contain three DNAse I hypersensitivity sites (HS3A, HS1,2 and HS4), which are responsible for enhancer activity and they all contain octamer motifs. 47, 48 Although these elements show strong functional synergy only when combined, HS1,2 is assumed to play the most important role in the control of transcription. 33, 34 Our finding that all three transcription factors do interact with the HS1,2 enhancer of C 1 and C 2 LCRs in Burkitt lymphoma cell lines is consistent with the observed ability of both Oct1 and Oct2 to bind to murine hs1,2. 49 It is also in line with the reported ability of BOB.1/OBF.1 to strongly enhance the activity of the 3´enhancer, induced by IL-4 and anti-CD40 antibody. 50 It has recently been shown that Oct1 or Oct2 preferentially recruit BOB.1/OBF.1 when they bind to a subset of octamer motifs, which have been called Palindromic Oct-factor Recognition Elements (POREs). 51, 52 The octamer motifs like those in the IgH promoter have been considered to be the prototypes of octamer motifs that do not recruit BOB. 55 .
Octamer motifs in Ig regulatory elements are inaccessible in cHL-derived cell lines
The 
Inhibition of DNA methylation results in reactivation of IgH transcription
Somewhat conflicting data have been published with respect to the expression of IgH RNA in different cHL cell lines. 8, 4, 18, 56 In line with recent results from Affymetrix GeneChip assays, we only found spliced Ig transcripts by RT-PCR in KM-H2 cells. 57 We hypothesized that epigenetic mechanisms could be responsible for the down-regulation of IgH expression. As outlined in the introduction, epigenetic silencing of so-called tumor suppressor genes has been identified as a common oncogenic mechanism, contributing to tumorigenesis. 19 Many of these genes could be reactivated by an inhibitor of the DNA 
